about
Bladder cancer in the elderly patient: challenges and solutionsRituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial.Frailty and inflammatory markers in older adults with cancerCirculating MicroRNAs as easy-to-measure aging biomarkers in older breast cancer patients: correlation with chronological age but not with fitness/frailty status.Management of breast cancer in the older woman.Management of complications of androgen deprivation therapy in the older man.Association of cancer with geriatric syndromes in older Medicare beneficiariesTREATMENT AND SURVIVAL PATTERNS IN RELATION TO MULTIMORBIDITY IN PATIENTS WITH LOCOREGIONAL BREAST AND COLORECTAL CANCERAssessment and interpretation of comorbidity burden in older adults with cancer.Biological ageing and frailty markers in breast cancer patientsTailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA.Oral versus intravenous vinorelbine: clinical safety profile.Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients.A Scoping Review of Frailty and Acute Care in Middle-Aged and Older Individuals with Recommendations for Future Research.The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters.Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiariesOptimal management of renal cell carcinoma in the elderly: a reviewOutcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi.
P2860
Q28082782-FA104415-7BFA-47D3-A1EA-EB1F1C9C2BF1Q33407102-AF394C36-D462-41E4-A33D-4BF1D5D93B44Q33563551-A04BCE8C-73FF-4C5C-8923-1C4B9E5DB566Q34380210-86C5AA11-B62F-4113-92EF-91EEDB219009Q34386713-15D77DBF-642D-48CE-BB94-8CBE2E59C184Q34782101-82C4E71E-434C-40B7-B0AD-DEBE40C04649Q34866406-8271C540-A6B8-48D2-8007-DCF12C12144CQ35117528-EAB6608C-B876-49D1-AFAB-5152F98006E5Q35419280-34912AE5-32D9-4319-B106-22524D29671FQ35744970-3C6899D4-2692-464D-90D7-D6E411FA2FE6Q35989968-A8A19618-20AB-44F7-9FCE-6291393E3312Q36235526-98593353-0C7A-42FA-9A3D-8FDF5BB3558EQ36299985-32B52772-5F05-434C-91EC-DE1DFFF2B143Q36342672-CB7CD42E-9789-4AC5-97AC-0B39F19ED62CQ37327398-E61F0C70-A686-4D05-95CA-A2A603CD8598Q37608744-69CA74C0-0838-4E56-98E9-F07B94D4133AQ38102680-2D71C295-7FBC-4E72-AF86-397E93E7A616Q43782234-64E79398-C33D-4258-9D45-1B0C43B8E8C7
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Management of the frail person with advanced cancer.
@ast
Management of the frail person with advanced cancer.
@en
type
label
Management of the frail person with advanced cancer.
@ast
Management of the frail person with advanced cancer.
@en
prefLabel
Management of the frail person with advanced cancer.
@ast
Management of the frail person with advanced cancer.
@en
P1476
Management of the frail person with advanced cancer.
@en
P2093
Balducci L
Extermann M
P304
P356
10.1016/S1040-8428(99)00063-3
P577
2000-02-01T00:00:00Z